Skip to main content
SpringerLink
Log in

Brainstem Gliomas

  • Chapter
  • First Online:
Book cover Pediatric CNS Tumors

Part of the book series: Pediatric Oncology ((PEDIATRICO))

Abstract

Pediatric brainstem gliomas are a heterogeneous group of tumors that arise from either the midbrain, pons, or medulla. These tumors make up between 10 and 20 % of all pediatric central nervous system tumors (Jallo et al. 2004; Gilbertson et al. 2003). In the United States, this means that there are approximately 350 new cases each year (Khatua et al. 2011). The serious symptoms and signs produced by these tumors, which range from isolated specific cranial nerve palsies to quadriparesis, are a consequence of the many important neurologic pathways that originate or pass through the brainstem.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aoki Y, Hashizume R, Ozawa T, Banerjee A, Prados M, James CD et al (2012) An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing. J Neuro-Oncol 108(1):29–35

    Article  Google Scholar 

  • Barua NU, Lowis SP, Woolley M, O’Sullivan S, Harrison R, Gill SS (2013) Robot-guided convection-enhanced delivery of carboplatin for advanced brainstem glioma. Acta Neurochir (Wien) 155(8):1459–1465

    Article  CAS  Google Scholar 

  • Bouffet E, Jakacki R, Goldman S et al (2012) Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma. J Clin Oncol 30(12):1358–1363

    Article  CAS  PubMed  Google Scholar 

  • Bradley KA, Zhou T, McNall-Knapp RY, Jakacki RI, Levy AS, Vezina G et al (2013) Motexafin-gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a children’s oncology group phase 2 study. Int J Radiat Oncol Biol Phys 85(1):e55–e60

    Article  CAS  PubMed  Google Scholar 

  • Bredlau AL, Korones DN (2014) Diffuse intrinsic pontine gliomas: treatments and controversies. Adv Cancer Res 121:235–259

    Article  CAS  PubMed  Google Scholar 

  • Broniscer A, Laningham FH, Sanders RP, Kun LE, Ellison DW, Gajjar A (2008) Young age may predict a better outcome for children with diffuse pontine glioma. Cancer 113(3):566–572

    Article  PubMed  Google Scholar 

  • Cage TA, Samagh SP, Mueller S et al (2013) Feasibility, safety, and indications for surgical biopsy of intrinsic brainstem tumors in children. Childs Nerv Syst 29(8):1313–1319

    Article  PubMed  Google Scholar 

  • Caretti V, Hiddingh L, Lagerweij T, Schellen P, Koken PW, Hulleman E et al (2013) WEE1 kinase inhibition enhances the radiation response of diffuse intrinsic pontine gliomas. Mol Cancer Ther 12(2):141–150

    Article  CAS  PubMed  Google Scholar 

  • Chan KM, Fang D, Gan H, Hashizume R, Yu C, Schroeder M, Gupta N, Mueller S, James CD, Jenkins R, Sarkaria J, Zhang Z (2013) The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression. Genes Dev 27:900–910

    Article  Google Scholar 

  • Children’s Oncology Group, National Cancer Institute. Vorinostat and radiation therapy followed by maintenance therapy with vorinostat in treating younger patients with newly diagnosed pontine glioma. ClinicalTrials.gov identifier NCT01189266. Accessed March 2016.

    Google Scholar 

  • Cillekens JM, Beliën JA, van der Valk P et al (2000) A histopathological contribution to supratentorial glioma grading, definition of mixed gliomas and recognition of low grade glioma with Rosenthal fibers. J Neuro-Oncol 46(1):23–43

    Article  CAS  Google Scholar 

  • Cohen KJ (2009) Current clinical management of children diagnosed with Diffuse Intrinsic Pontine Glioma (DIPG). In: Joint Meeting of the Pediatric and Oncologic Drugs Advisory Committees, 27 April 2009

    Google Scholar 

  • Donaldson SS, Laningham F, Fischer PG (2008) Advances towards an understanding of brainstem gliomas. J Clin Oncol 24(8):1266–1272

    Article  Google Scholar 

  • Epstein FJ, Farmer JP (1993) Brain-stem glioma growth patterns. J Neurosurg 78(3):408–412

    Google Scholar 

  • Farmer JP, Montes JL, Freeman CR, Meagher-Villemure K, Bond MC, O’Gorman AM (2001) Brainstem gliomas. A 10-year institutional review. Pediatr Neurosurg 34(4):206–214

    Article  CAS  PubMed  Google Scholar 

  • Finlay JL, Zacharoulis S (2005) The treatment of high grade gliomas and diffuse intrinsic pontine tumors of childhood and adolescence: a historical – and futuristic – perspective. J Neuro-Oncol 75(3):253–266

    Article  CAS  Google Scholar 

  • Frazier JL, Lee J, Thomale UW et al (2009) Treatment of diffuse intrinsic brainstem gliomas: failed approaches and future strategies. Journal of neurosurgery. Pediatrics 3(4); 259–269

    Google Scholar 

  • Freeman CR, Farmer JP (1998) Pediatric brain stem gliomas: a review. International journal of radiation oncology, biology, physics, 40(2): 265–271

    Google Scholar 

  • Freeman CR, Krischer JP, Sanford RA, Cohen ME, Burger PC, del Carpio R, Halperin EC, Munoz L, Friedman HS, Kun LE (1993) Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study. Int J Radiat Oncol Biol Phys 27:197–206

    Article  CAS  PubMed  Google Scholar 

  • Gilbertson RJ, Hill DA, Hernan R, Kocak M, Geyer R, Olson J et al (2003) ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma. Clin Cancer Res 9(10 Pt 1):3620–3624

    CAS  PubMed  Google Scholar 

  • Grill J, Puget S, Andreiuolo F et al (2012) Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma. Pediatr Blood Cancer 58:489

    Article  PubMed  Google Scholar 

  • Guillamo JS, Doz F, Delattre JY (2001) Brain stem gliomas. Curr Opin Neurol 14(6):711–715

    Article  CAS  PubMed  Google Scholar 

  • Gururangan S, Cavazos CM, Ashley D et al (2002) Phase II study of carboplatin in children with progressive low-grade gliomas. J Clin Oncol 20(13):2951–2958

    Article  CAS  PubMed  Google Scholar 

  • Gururangan S, Fangusaro J, Poussaint TY et al (2014) Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas – a Pediatric Brain Tumor Consortium study. Neuro-Oncology 16(2):310–317

    Article  CAS  PubMed  Google Scholar 

  • Haas-Kogan DA, Banerjee A, Poussaint TY et al (2011) Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas. Neuro Oncol 13(3):298–306

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hashizume R, Smirnov I, Liu S et al (2012) Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment. J Neuro-Oncol 110(3):305–313

    Article  Google Scholar 

  • Hashizume R, Andor N, Ihara Y et al (2014) Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma. Nat Med 20:1394–1396

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jakacki RI, Bouffet E, Adamson PC et al (2011) A phase 1 study of vinblastine in combination with carboplatin for children with low-grade gliomas: a Children’s Oncology Group phase 1 consortium study. Neuro-Oncology 13(8):910–915

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jallo GI, Biser Rohrbaugh A, Freed D (2004) Brainstem gliomas. Childs Nerv Syst 20(3):143–153

    Article  PubMed  Google Scholar 

  • Jones C, Baker SJ (2014) Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma. Nat Rev Cancer 14(10):651–661

    Google Scholar 

  • Kaplan AM, Albright AL, Zimmerman RA et al (1996) Brainstem gliomas in children. A Children’s Cancer Group review of 119 cases. Pediatr Neurosurg 24(4):185–192

    Article  CAS  PubMed  Google Scholar 

  • Kebudi R, Cakir FB (2013) Management of diffuse pontine gliomas in children: recent developments. Pediatr Drugs 15(5):351–362

    Article  Google Scholar 

  • Khatua S, Moore KR, Vats TS et al (2011) Diffuse intrinsic pontine glioma – current status and future strategies. Childs Nerv Syst 27:1391–1397

    Article  PubMed  Google Scholar 

  • Khaw SL, Coleman LT, Downie PA et al (2007) Temozolomide in pediatric low-grade glioma. Pediatr Blood Cancer 49(6):808–811

    Article  PubMed  Google Scholar 

  • Kornreich L, Schwarz M, Karmazyn B, Cohen IJ, Shuper A, Michovitz S et al (2005) Role of MRI in the management of children with diffuse pontine tumors: a study of 15 patients and review of the literature. Pediatr Radiol 35(9):872–879

    Article  PubMed  Google Scholar 

  • Korones DN, Kretschmar CS, Freeman CR, Fisher PG, Zhou T, Kepner J (2003) Treatment of children with diffuse intrinsic brain stem glioma with standard dose irradiation and vincristine plus oral VP-16. A Pediatric Oncology Group study. Eighth Annual meeting of Society for Neuro-Oncology, Keystone, Colorado, November 13–16, 2003. Neuro-Oncology 5(4):359

    Google Scholar 

  • Lazareff JA, Bockhorst KH, Curran J et al (1998) Pediatric low-grade gliomas: prognosis with proton magnetic resonance spectroscopic imaging. Neurosurgery 43(4):809–817; discussion 817

    Article  CAS  PubMed  Google Scholar 

  • Lewis PW, Müller MM, Koletsky MS et al (2013) Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 340:857

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lonser RR, Warren KE, Butman JA et al (2007) Real-time image-guided direct convective perfusion of intrinsic brain stem lesions. J Neurosurg 107:190–197

    Article  PubMed  Google Scholar 

  • Louis DN, Rubio MP, Correa KM, Gusella JF, von Deimling A (1993) Molecular genetics of pediatric brain stem gliomas. Application of PCR techniques to small and archival brain tumor specimens. J Neuropathol Exp Neurol 52(5):507–515

    Article  CAS  PubMed  Google Scholar 

  • Mandell LR, Kadota R, Freeman C, Douglass EC, Fontanesi J, Cohen ME et al (1999) There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys 43(5):959–964

    Article  CAS  PubMed  Google Scholar 

  • Masoudi A, Elopre M, Amini E et al (2008) Influence of valproic acid on outcome of high-grade gliomas in children. Anticancer Res 28:2437–2442

    PubMed  Google Scholar 

  • Mueller S, Hashizume R, Yang X et al (2014) Targeting Wee1 for the treatment of pediatric high-grade gliomas. Neuro-Oncology 16(3):352–360

    Article  CAS  PubMed  Google Scholar 

  • Nicholson HS, Kretschmar CS, Krailo M et al (2007) Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children’s Oncology Group. Cancer 110(7):1542–1550

    Article  CAS  PubMed  Google Scholar 

  • Packer RJ, Boyett JM, Zimmerman RA et al (1994) Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I/II Trial. Cancer 74(6):1827–1834

    Article  CAS  PubMed  Google Scholar 

  • Paugh BS, Broniscer A, Qu C et al (2011) Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J Clin Oncol 29:3999

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pollack IF, Shultz B, Mulvihill JJ (1996) The management of brainstem gliomas in patients with neurofibromatosis 1. Neurology 46(6):1652–1660

    Article  CAS  PubMed  Google Scholar 

  • Pollack IF, Jakacki RI, Blaney SM et al (2007) Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report. Neuro Oncol 9:145–160

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Prados MD, Wara WM, Edwards MSB et al (1995) The treatment of brain stem and thalamic gliomas with 78 Gy of hyperfractionated radiation therapy. Int J Radiat Oncol Biol Phys 32:85–91

    Article  CAS  PubMed  Google Scholar 

  • Puget S, Philippe C, Bax DA et al (2012) Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas. PLoS ONE 7, e30313

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Qi S, Yu L, Li H et al (2014) Isocitrate dehydrogenase mutation is associated with tumor location and magnetic resonance imaging characteristics in astrocytic neoplasms. Oncol Lett 7(6):1895–1902

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ramos A, Hilario A, Lagares A et al (2013) Brainstem gliomas. Semin Ultrasound CT MRI 34:104–112

    Article  Google Scholar 

  • Robertson T, Koszyca B, Gonzales M (2011) Overview and recent advances in neuropathology. Part 1: central nervous system tumours. Pathology 43(2):88–92

    Article  PubMed  Google Scholar 

  • Sanghavi SN, Needle MN, Krailo MD, Geyer JR, Ater J, Mehta MP (2003) A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children’s Cancer Group-0952. Neuro-Oncology 5(1):8–13

    CAS  PubMed  PubMed Central  Google Scholar 

  • Schindler G, Capper D, Meyer J et al (2011) Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121(3):397–405

    Article  CAS  PubMed  Google Scholar 

  • Schomerus L, Merkenschlager A, Kahn T et al (2007) Spontaneous remission of a diffuse brainstem lesion in a neonate. Pediatr Radiol 37(4):399–402

    Article  PubMed  Google Scholar 

  • Ullrich NJ, Raja AI, Irons MB et al (2007) Brainstem lesions in neurofibromatosis type 1. Neurosurgery 61(4):762–766; discussion 766

    Article  PubMed  Google Scholar 

  • Walker DA, Punt JA, Sokal M (1999) Clinical management of brain stem glioma. Arch Dis Child 80:558–564

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Walker DA, Punt JAG, Sokal M (2004) Brainstem tumors. Arnold, London

    Book  Google Scholar 

  • Walker DA, Liu J, Kieran M et al (2013) A multi-disciplinary consensus statement concerning surgical approaches to low-grade, high-grade astrocytomas and diffuse intrinsic pontine gliomas in childhood (CPN Paris 2011) using the Delphi method. Neuro-Oncology 15(4):462–468

    Article  PubMed  PubMed Central  Google Scholar 

  • Warren K, Bent R, Wolters PL, Prager A, Hanson R, Packer R et al (2012) A phase 2 study of pegylated interferon alpha-2b (PEG-Intron((R))) in children with diffuse intrinsic pontine glioma. Cancer 118(14):3607–3613

    Article  CAS  PubMed  Google Scholar 

  • Wu G, Broniscer A, McEachron TA et al (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44:251

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wu G, Diaz AK, Paugh BS et al (2014) The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet 46(5):444–450

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zaky W, Wellner M, Brown RJ et al (2013) Treatment of children with diffuse intrinsic pontine gliomas with chemoradiotherapy followed by a combination of temozolomide, irinotecan, and bevacizumab. Pediatr Hematol Oncol 30(7):623–632

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology, Department of Pediatrics, University of California San Francisco & UCSF Benioff Children’s Hospital, 550 16th Street Box 0434, San Francisco, CA, 94143, USA

    Tiffany F. Lin MD

  2. Departments of Neurological Surgery & Pediatrics, University of California San Francisco, Hellen Diller Cancer Center Building, Room HD 487 D, 1450 3rd Street, San Francisco, CA, 94143-0520, USA

    Michael Prados MD

Authors
  1. Tiffany F. Lin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Prados MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Prados MD .

Editor information

Editors and Affiliations

  1. San Francisco, California, USA

    Nalin Gupta

  2. San Francisco, California, USA

    Anuradha Banerjee

  3. Boston, Massachusetts, USA

    Daphne A. Haas-Kogan

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing

About this chapter

Cite this chapter

Lin, T.F., Prados, M. (2017). Brainstem Gliomas. In: Gupta, N., Banerjee, A., Haas-Kogan, D. (eds) Pediatric CNS Tumors. Pediatric Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-30789-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-30789-3_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-30787-9

  • Online ISBN: 978-3-319-30789-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation